A. Moriguchi

发表

A Combined Treatment with Tacrolimus (FK506) and Recombinant Tissue Plasminogen Activator for Thrombotic Focal Cerebral Ischemia in Rats: Increased Neuroprotective Efficacy and Extended Therapeutic Time Window

T. Yanagihara, Y. Furuichi, N. Matsuoka, 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Comparison of the course of biomarker changes and kidney injury in a rat model of drug-induced acute kidney injury

Daisuke Sasaki, H. Kurihara, J. Seki, 2011, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

FK419, a Novel Nonpeptide GPIIb/IIIa Antagonist, Restores Microvascular Patency and Improves Outcome in the Guinea-Pig Middle Cerebral Artery Thrombotic Occlusion Model: Comparison with Tirofiban

T. Aoki, N. Matsuoka, M. Maeda, 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Prohemorrhagic and bleeding time activities of recombinant tissue plasminogen activator, heparin, aspirin, and a glycoprotein IIb/IIIa antagonist.

Y. Furuichi, T. Aoki, N. Matsuoka, 2005, Journal of neurotrauma.

FK419, a Nonpeptide Platelet Glycoprotein IIb/IIIa Antagonist, Ameliorates Brain Infarction Associated with Thrombotic Focal Cerebral Ischemia in Monkeys: Comparison with Tissue Plasminogen Activator

T. Aoki, N. Matsuoka, M. Maeda, 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Antithrombotic Effects of FK419, a Novel Nonpeptide Platelet GPIIb/IIIa Antagonist, in a Guinea Pig Photochemically Induced Middle Cerebral Artery Thrombosis Model: Comparison with Ozagrel and Argatroban

T. Aoki, N. Matsuoka, N. Tojo, 2004, Journal of Pharmacology and Experimental Therapeutics.

Restoration of middle cerebral artery thrombosis by novel glycoprotein IIb/IIIa antagonist FK419 in guinea pig.

T. Aoki, N. Matsuoka, N. Tojo, 2004, European journal of pharmacology.

Neuroprotective action of tacrolimus (FK506) in focal and global cerebral ischemia in rodents: dose dependency, therapeutic time window and long-term efficacy

T. Yanagihara, Y. Furuichi, N. Matsuoka, 2003, Brain Research.

Tacrolimus, a Potential Neuroprotective Agent, Ameliorates Ischemic Brain Damage and Neurologic Deficits after Focal Cerebral Ischemia in Nonhuman Primates

T. Yanagihara, Y. Furuichi, N. Matsuoka, 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Angiotensin II type 1 receptor blocker preserves tolerance to ischemia-reperfusion injury in Dahl salt-sensitive rat heart.

T. Iwasaka, H. Otani, A. Moriguchi, 2008, American journal of physiology. Heart and circulatory physiology.

Cardiovascular Outcome and Mortality in Patients Undergoing Endovascular Treatment for Symptomatic Peripheral Artery Disease　- Short-Term Results of the Toma-Code Registry.

T. Kodama, A. Mizuno, H. Anzai, 2018, Circulation journal : official journal of the Japanese Circulation Society.

[Hypoadiponectinemia implies the development of atherosclerosis in carotid and coronary arteries].

M. Matsuda, T. Uegaito, K. Manabe, 2005, Journal of cardiology.

Neuroprotective Efficacy of the Peroxisome Proliferator-Activated Receptor δ-Selective Agonists in Vitro and in Vivo

A. Iwashita, N. Matsuoka, T. Yamazaki, 2007, Journal of Pharmacology and Experimental Therapeutics.

Neuroprotective Efficacy of the Peroxisome Proliferator-Activated Receptor delta (PPAR-δ) Selective Agonists, L-165041 and GW501516, in Vitro and in Vivo

A. Iwashita, N. Matsuoka, T. Yamazaki, 2006 .

N-acetylcysteine abolishes the protective effect of losartan against left ventricular remodeling in cardiomyopathy hamster.

T. Iwasaka, H. Otani, A. Moriguchi, 2008, Antioxidants & redox signaling.

Inhibition of contractile activity during postconditioning enhances cardioprotection by restoring sarcolemmal dystrophin through phosphatidylinositol 3-kinase.

T. Iwasaka, H. Otani, A. Moriguchi, 2010, Circulation journal : official journal of the Japanese Circulation Society.

Neuroprotective efficacy of FR901459, a novel derivative of cyclosporin A, in in vitro mitochondrial damage and in vivo transient cerebral ischemia models

Y. Furuichi, M. Hino, N. Matsuoka, 2007, Brain Research.

Association of the antagonism of von Willebrand factor but not fibrinogen by platelet αIIbβ3 antagonists with prolongation of bleeding time

S. Honda, Y. Tomiyama, T. Aoki, 2005 .

Multiple modes of action of tacrolimus (FK506) for neuroprotective action on ischemic damage after transient focal cerebral ischemia in rats

T. Yanagihara, Y. Furuichi, I. Aramori, 2004, Brain Research.

FK960, a novel potential anti-dementia drug, enhances high K+-evoked release of somatostatin from rat hippocampal slices

N. Matsuoka, A. Moriguchi, T. Goto, 2001, Brain Research.

Characterization of the anti‐platelet actions of FK419, a novel non‐peptide antagonist of platelet GPIIb/IIIa

T. Aoki, Hiroko Yamamoto, N. Matsuoka, 2004 .

Urinary proteome profile of renal papillary necrosis in experimental model rats

A. Naganuma, A. Unami, Gi-Wook Hwang, 2017 .

Identification of urinary miRNA biomarkers for detecting cisplatin-induced proximal tubular injury in rats.

A. Unami, Masayuki Kanki, Daisuke Sasaki, 2014, Toxicology.

Neuroprotective effect of tacrolimus (FK506) on ischemic brain damage following permanent focal cerebral ischemia in the rat.

T. Yanagihara, I. Aramori, N. Matsuoka, 2004, Brain research. Molecular brain research.

FK960, a potential anti-dementia drug, increases synaptic density in the hippocampal CA3 region of aged rats

N. Matsuoka, M. Hashimoto, K. Noda, 2002, Brain Research.